Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Knerr

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Expert Opinion on Therapeutic Patents|November 20, 2010
T-type calcium channels inhibitors: a patent reviewFabrizio Giordanetto, Laurent Knerr, Andreas Wållberg
Journal of Combinatorial Chemistry|September 14, 2004
New synthetic pathway to diverse 2-substituted quinolines based on a multicomponent reaction: solution-phase and solid-phase applicationsThierry Demaude, Laurent Knerr, Patrick Pasau
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 18, 2018
Synthesis of Diverse α-Fluoroalkoxyaryl Derivatives and Their Use for the Generation of Fluorinated MacrocyclesThomas J Cogswell, Anders Dahlén, Laurent Knerr
Drug Discovery Today|December 19, 2016
Targeted delivery for regenerative medicines: an untapped opportunity for drug conjugatesEric Valeur, Laurent Knerr, Maria Ölwegård-Halvarsson, et al.
Angewandte Chemie (International Ed. in English)|August 11, 2024
Accessing Therapeutically-Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical LigationDaniel Engelhardt, Peter Nordberg, Laurent Knerr, et al.
Chemical Communications (Cambridge, England)|September 18, 2018
Exploring physicochemical space via a bioisostere of the trifluoromethyl and ethyl groups (BITE): attenuating lipophilicity in fluorinated analogues of Gilenya® for multiple sclerosisNathalie Erdeljac, Gerald Kehr, Marie Ahlqvist, et al.
Organic Letters|October 6, 2017
Direct Synthesis of N-Alkyl Arylglycines by Organocatalytic Asymmetric Transfer Hydrogenation of N-Alkyl Aryl Imino EstersJavier Mazuela, Thomas Antonsson, Magnus J Johansson, et al.
Angewandte Chemie (International Ed. in English)|January 29, 2014
Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agentsAlleyn T Plowright, Ola Engkvist, Adrian Gill, et al.
Journal of Medicinal Chemistry|July 1, 2016
Therapeutic Potential of Foldamers: From Chemical Biology Tools To Drug Candidates?Ranganath Gopalakrishnan, Andrey I Frolov, Laurent Knerr, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2014
Design, synthesis, and SAR of a series of activated protein C (APC) inhibitors with selectivity against thrombin for the treatment of haemophiliaPeter Bach, Laurent Knerr, Ola Fjellström, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Expert Opinion on Therapeutic Patents|November 20, 2010
T-type calcium channels inhibitors: a patent reviewFabrizio Giordanetto, Laurent Knerr, Andreas Wållberg
Journal of Combinatorial Chemistry|September 14, 2004
New synthetic pathway to diverse 2-substituted quinolines based on a multicomponent reaction: solution-phase and solid-phase applicationsThierry Demaude, Laurent Knerr, Patrick Pasau
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 18, 2018
Synthesis of Diverse α-Fluoroalkoxyaryl Derivatives and Their Use for the Generation of Fluorinated MacrocyclesThomas J Cogswell, Anders Dahlén, Laurent Knerr
Drug Discovery Today|December 19, 2016
Targeted delivery for regenerative medicines: an untapped opportunity for drug conjugatesEric Valeur, Laurent Knerr, Maria Ölwegård-Halvarsson, et al.
Angewandte Chemie (International Ed. in English)|August 11, 2024
Accessing Therapeutically-Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical LigationDaniel Engelhardt, Peter Nordberg, Laurent Knerr, et al.
Chemical Communications (Cambridge, England)|September 18, 2018
Exploring physicochemical space via a bioisostere of the trifluoromethyl and ethyl groups (BITE): attenuating lipophilicity in fluorinated analogues of Gilenya® for multiple sclerosisNathalie Erdeljac, Gerald Kehr, Marie Ahlqvist, et al.
Organic Letters|October 6, 2017
Direct Synthesis of N-Alkyl Arylglycines by Organocatalytic Asymmetric Transfer Hydrogenation of N-Alkyl Aryl Imino EstersJavier Mazuela, Thomas Antonsson, Magnus J Johansson, et al.
Angewandte Chemie (International Ed. in English)|January 29, 2014
Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agentsAlleyn T Plowright, Ola Engkvist, Adrian Gill, et al.
Journal of Medicinal Chemistry|July 1, 2016
Therapeutic Potential of Foldamers: From Chemical Biology Tools To Drug Candidates?Ranganath Gopalakrishnan, Andrey I Frolov, Laurent Knerr, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2014
Design, synthesis, and SAR of a series of activated protein C (APC) inhibitors with selectivity against thrombin for the treatment of haemophiliaPeter Bach, Laurent Knerr, Ola Fjellström, et al.
Pageof 4